What's new in transapical aortic valve implantation: Clinical experience with second generation devices

Minerva Cardioangiologica

Volumn 61, Issue 3, 2013, Pages 341-349

  Conradi, L ^a   Seiffert, M ^a   Blankenberg, S ^a   Reichenspurner, H ^a   Diemert, P ^a   Treede, H ^a  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

Aortic valve; Aortic valve stenosis; Heart valve prosthesis implantation

Indexed keywords

ACUTE KIDNEY FAILURE; HUMAN; MORTALITY; NEUROLOGICAL COMPLICATION; PATIENT SAFETY; PERCUTANEOUS AORTIC VALVE; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURVIVAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; CLINICAL TRIALS AS TOPIC; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; PROSTHESIS DESIGN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84879760406     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F et at. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcified aortic stenosis. Circulation 2002;106:3006-8. (Pubitemid 35440280)
2. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
3. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
4. Conradi L, Seiffert M, Treede H, Silaschi M, Baldus S, Schirmer J et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement: a propensity score analysis in patients at high surgical risk. J Thorac Cardiovasc Surg 2012;143:64-71.
5. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H et al. Guidelines on the management of valvular heart disease (version 2012). Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451-96.
6. Holmes DR Jr, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 2012;59:1200-54.
7. Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H et al. One-year outcomes of cohort 1 in the Edwards Sapien Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011;124:425-33.
8. Linke A, Gerckens U, Wenaweser P, Tamburino C, Bosnians J, Breckerand S et al. Treatment of high risk aortic stenosis patients with transcatheter Medtronic CoreValve implantation: results from the international multi-center ADVANCE study. J Am Coll Cardiol 2012;59:8.
9. Lauten A, Ferrari M, Petri A, Ensminger SM, Gummert JF, Boudjemline Y et al. Experimental evaluation of the JenaClip transcatheter aortic valve. Catheter Cardiovasc Interv 2009;74:514-9.
10. Kempfert J, Rastan AJ, Mohr FW, Walther T. A new self-expanding transcatheter aortic valve for transapical implantation - first in man implantation of the JenaValve™. Eur J Cardiothorac Surg 2011;40:761-3.
11. Treede H, Mohr FW, Baldus S, Rastan A, Ensminger S, Arnold M et al. Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicenter CE-mark study. Eur J Cardiothorac Surg 2012;41:e131-8.
12. Treede H. Transapical aortic valve implantation: 6 and 12 months results from a multicenter study using the JenaValve second generation transcatheter aortic valve implantation system. TCT Meeting 2012, Miami Beach, FL, USA; 22-26 October 2012.
13. Seiffert M, Diemert P, Koschyk D, Schirmer J, Conradi L, Schnable R et al. Transapical implantation of a second-generation transcatheter heart valve in patients with non-calcified aortic regurgitation. JACC Cardiovasc Interv [In press].
14. Kempfert J, Rastan A, Beyersdorf F, Schönburg M, Schuler G, Sorg S et al. Trans-apical aortic valve implantation using a new self-expandable bioprosthesis: initial outcomes. Eur J Cardiothorac Surg 2011;40:1114-9.
15. Kempfert J, Treede H, Rastan AJ, Schönburg M, Thielmann M, Sorg S et al. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TATM): 6-month outcomes. Eur J Cardiothorac Surg 2013;43:52-7.
16. Treede H. Updates from the transapical program SYMETIS ACURATE TA™. Transcatheter Cardiovascular Therapeutics meeting 2012, Miami Beach, FL, USA; 22-26 October 2012.
17. Falk V, Walther T, Schwammenthal E, Strauch J, Aicher D, Wahlers T et al. Transapical aortic valve implantation with a self-expanding anatomically oriented valve. Eur Heart J 2011;32:878-87.
18. Sündermann SH, Grünenfelder J, Corti R, Ardawan JR, Linke A, Lange R et al. Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design. Eur J Cardiothorac Surg 2012;42:e48-52.
19. Treede H. Engager CE Pivotal Trial Interim Analysis. European Association for Cardio-thoracic Surgery Annual Meeting 2012, Barcelona, Spain; 27-31 October 2012.
20. Kappetein AP, Head SJ, Treede H, Reichenspurner H, Mohr FW, Walther T. What is the evidence allowing us to state that transcatheter aortic valve replacement via the femoral artery is a more attractive option compared to transapical valve replacement? Eurointervention 2011;7:903-4.
21. Kiefer P, Gruenwald F, Kempfert J, Aupperle H, Seeburger J, Mohr FW et al. Crimping may affect the durability of transcatheter valves: an experimental analysis. Ann Thorac Surg 2011;92:155-60.